|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
GEHE Pharma Praha spol .s r.o.
Main Activities: Wholesale Trade - Merchant Wholesalers, Nondurable Goods
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name GEHE Pharma Praha spol .s r.o. Previous name(s) SMC pharma s r.o. (1993) Svycarske zdravotnicke centrum spol. s r.o. Praha (1992) Headquarters Nadrazni 344/23; Praga; The City of Prague; 15000 |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational CZ-ICO: 14888742 Financial Auditors: Ernst & Young (2011) Incorporation Date: February 21, 1991 Total Employees: 250 Tel: +420 225 996100 |
|
Company Description |
| GEHE Pharma Praha, spol. s r.o. belongs to one of the major pharmaceutical wholesale business in the Czech Republic. The company belongs to a Celesio AG group and it has 3 branches in Czech republic: in Prague, Brno and Ostrava. |
Company Analysis |
 For the latest financial data available click here.The company GEHE Pharma Praha,spol.s r.o. posted in 2009 in accordance with the Local Accounting Standards a non-consolidated profit of CZK 29.54 mn. Compared with the previous period, when loss amounted to CZK 25.4 mn, it showed a CZK 54.94 mn increase. Revenues within the observed period reached CZK 9.35 bn, while in the previous year it amounted to CZK 8.06 bn, which is 16.06% more. At the end of the year, total assets were reported at CZK 2.86 bn, return on assets (ROA) reached 1.03%, return on equity (ROE) 15.92% and return on sales (ROS) 0.32%. |
Key Executives |
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2010 Y (non-cons) |
2009 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| ISI Company Financials | ISI Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
3,438,070 |
2,855,490 |
| ||
Current Assets |
X,XXX,XXX |
X,XXX,XXX |
| ||
Total Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
Shareholders Equity |
XXX,XXX |
XXX,XXX |
| ||
Current Liabilities |
X,XXX,XXX |
X,XXX,XXX |
| ||
| * All the accounts are in CZK. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Operational Profit (Loss) |
XXX,XXX |
XX,XXX |
| ||
Net Profit (Loss) |
XX,XXX |
XX,XXX |
| ||
| * All the accounts are in CZK. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Annualised Return on Assets (ROA) |
X.XX% |
X.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Capital |
X.XX% |
X.XX% |
| ||
Gross Profit Margin |
X.X% |
X.XX% |
| ||
Operating Profit Margin |
X.X% |
X.XX% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
X.XXx |
X.XXx |
| ||
Inventory Turnover |
XX.XXx |
XX.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
XXX.XXx |
XXX.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX,XXX |
XX,XXX |
| ||
EBITDA |
XXX,XXX |
XXX,XXX |
| ||
Bookvalue (BV) |
-XXX |
-XXX |
| ||
Net Cash |
-X,XXX,XXX |
-X,XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XXX.XX% |
XXX.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
X,XXX.XX% |
X,XXX.XX% |
| ||
Interest Coverage Ratio |
XXX.XX% |
XXX.XX% |
| ||
Debt to equity |
X,XXX.XX% |
X,XXX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
Long Term Debt to Capital |
XXX.XX% |
XXX.XX% |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX.XX% |
XXX.XX% |
| ||
Net Income Trend |
XXX.XX% |
-XXX.XX% |
| ||
Operating Income Trend |
XXX.XX% |
XXX.XX% |
| ||
 |